| Hamid Mukhtar, MD | |
|
2649 Schoenersville Rd Ste 100, Bethlehem, PA 18017-7326 | |
| (484) 884-8110 | |
| (610) 868-5333 |
| Full Name | Hamid Mukhtar |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 2649 Schoenersville Rd Ste 100, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134455892 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD465716 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Home Care | Allentown, PA | Home health agency |
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Texas Health Arlington Memorial Hospital | Arlington, TX | Hospital |
| Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
MIT biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system, on a specialized microfluidic platform seeded with human cells.
Now, in new research, the everyday painkiller aspirin will be evaluated as a potential treatment for COVID-19 in one of the United Kingdom's most significant trials, aiming to evaluate whether it can reduce the risk of blood clots in infected people.
According to drug company Pfizer the results of two mid-stage studies on its experimental cholesterol drug torcetrapib, combined with its cholesterol drug Lipitor, were so promising that the company will continue into the final stage.
Hamamatsu Photonics K.K. is pleased to announce that is has been awarded Reissue Patent No. 42,220, confirming the patentability of its original Patent 6,847,729, a pioneering patent directed to slide scanning with remote viewing.
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
› Verified 5 days ago
| Entity Name | Aria Health Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750949806 PECOS PAC ID: 3577467018 Enrollment ID: O20040224000045 |
News Archive
MIT biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system, on a specialized microfluidic platform seeded with human cells.
Now, in new research, the everyday painkiller aspirin will be evaluated as a potential treatment for COVID-19 in one of the United Kingdom's most significant trials, aiming to evaluate whether it can reduce the risk of blood clots in infected people.
According to drug company Pfizer the results of two mid-stage studies on its experimental cholesterol drug torcetrapib, combined with its cholesterol drug Lipitor, were so promising that the company will continue into the final stage.
Hamamatsu Photonics K.K. is pleased to announce that is has been awarded Reissue Patent No. 42,220, confirming the patentability of its original Patent 6,847,729, a pioneering patent directed to slide scanning with remote viewing.
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
› Verified 5 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
MIT biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system, on a specialized microfluidic platform seeded with human cells.
Now, in new research, the everyday painkiller aspirin will be evaluated as a potential treatment for COVID-19 in one of the United Kingdom's most significant trials, aiming to evaluate whether it can reduce the risk of blood clots in infected people.
According to drug company Pfizer the results of two mid-stage studies on its experimental cholesterol drug torcetrapib, combined with its cholesterol drug Lipitor, were so promising that the company will continue into the final stage.
Hamamatsu Photonics K.K. is pleased to announce that is has been awarded Reissue Patent No. 42,220, confirming the patentability of its original Patent 6,847,729, a pioneering patent directed to slide scanning with remote viewing.
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hamid Mukhtar, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Hamid Mukhtar, MD 2649 Schoenersville Rd Ste 100, Bethlehem, PA 18017-7326 Ph: (484) 884-8110 |
News Archive
MIT biological engineers have created a multitissue model that lets them study the relationships between different organs and the immune system, on a specialized microfluidic platform seeded with human cells.
Now, in new research, the everyday painkiller aspirin will be evaluated as a potential treatment for COVID-19 in one of the United Kingdom's most significant trials, aiming to evaluate whether it can reduce the risk of blood clots in infected people.
According to drug company Pfizer the results of two mid-stage studies on its experimental cholesterol drug torcetrapib, combined with its cholesterol drug Lipitor, were so promising that the company will continue into the final stage.
Hamamatsu Photonics K.K. is pleased to announce that is has been awarded Reissue Patent No. 42,220, confirming the patentability of its original Patent 6,847,729, a pioneering patent directed to slide scanning with remote viewing.
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
› Verified 5 days ago
Marie Eloise Antoine Pena-teotico, M.D.-M.B.A. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 | |
Dr. Mark Andrew Scaccia, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 148-452-6664 | |
Douglas Prechtel, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-6643 | |
Dr. Komal Bhavin Dumaswala, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 801 Ostrum St, St. Lukes Internal Medicine, Bethlehem, PA 18015 Phone: 484-526-6643 | |
Ayoola Olukunmi Oladejo, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 | |
Dr. Nicole Lynn Grube, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 Fax: 484-884-9297 |